The locally advanced pancreatic cancer treatment market is expanding as experience grows with combination regimens such as FOLFIRINOX and nab‑paclitaxel, alongside increasing use of neoadjuvant chemo‑radiation protocols and advanced diagnostic staging. https://www.datamintelligence.com/research-report/locally-advanced-pancreatic-cancer-market